FTO and prostate carcinoma: Notably, FTO has been linked to immune evasion mechanisms by downregulating the expression of immune-stimulating genes, implicating that FTO overexpression in lung and prostate cancers may impair CD70/CD80-mediated immune activation [68,69], though direct casual effects on CD70/CD80 require experimental confirmation.